BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 25, 2010
View Archived Issues
AGN-203818 useful to reduce hypersensitivity in heartburn and IBS patients
Read More
Acute rejection rates similar with CP-690550 and ciclosporin in renal transplant patients
Read More
Pfizer identifies new fatty-acid amide hydrolase inhibitors
Read More
Ranolazine exhibits antifibrillatory activity during severe coronary stenosis
Read More
Phase II data in cystic fibrosis disclosed on TR-02
Read More
Clinical safety and pharmacokinetic data of inhaled liposomal ciprofloxacin reported
Read More
Comparable safety/efficacy/tolerability of ilaprazole and esomeprazole in duodenal ulcer
Read More
Increased IGFBP-7 expression reduces breast cancer growth
Read More
Lundbeck reports highlights of first quarter 2010
Read More
NeuroTherapeutics closes series B financing to advance pipeline
Read More
Vagifem 10-mcg tablets replace 25-mcg formulation for atrophic vaginitis
Read More
Anadys reports on phase II combination trial of ANA-598
Read More
AndroScience and Orient Europharma collaborate on topical acne therapy
Read More
Bayer Schering Pharma claims new MEK 1 inhibitors
Read More
Janssen describes new serotonin receptor ligands
Read More
Ligand acquires milestone and royalty interest in MEDI-528 for asthma
Read More
New mGlu5 receptor antagonists claimed by GlaxoSmithKline
Read More
Sorrento Therapeutics receives NIH grant for innovative MRSA infection program
Read More
Grifols acquires Pharmalink's post-polio syndrome drug development project
Read More
NORD awards Shire for developing VPRIV in Gaucher's disease
Read More
Elagolix meets all efficacy endpoints in phase II trial in endometriosis
Read More
FDA extends review period of FTY-720 in relapsing MS
Read More
New data on coadministration of Intuniv and stimulants in ADHD
Read More
Enrollment complete in phase II brentuximab vedotin trial in ALCL
Read More
Phase III data reported on clobazam in Lennox-Gastaut syndrome
Read More
Intercell honored for developing IC-51 Japanese encephalitis vaccine
Read More